Literature DB >> 16231373

Molecular alterations during development of esophageal adenocarcinoma.

Dorine A Bax1, Peter D Siersema, Arnoud H M Van Vliet, Ernst J Kuipers, Johannes G Kusters.   

Abstract

The incidence of esophageal adenocarcinoma has risen significantly over the last decades. During esophageal carcinogenesis many molecular alterations occur that disrupt essential cellular processes, directing the cell to a rapidly proliferating, immortal state. The chronic inflammation that is present in Barrett's esophagus creates an environment in which such molecular alterations are both induced and tolerated. Here, the novel insights in the molecular mechanisms that underlie the development of esophageal adenocarcinoma are reviewed, focusing on the role of inflammation, angiogenesis, apoptosis inhibition, loss of cell cycle control, and loss of cell-cell adhesion. These novel developments will open new perspectives for diagnosis, treatment, and prevention of esophageal adenocarcinoma. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231373     DOI: 10.1002/jso.20353

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  1 in total

1.  Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival.

Authors:  Tushar H Sankalecha; Sudhir J Gupta; Nitin R Gaikwad; Nikhil U Shirole; Harit G Kothari
Journal:  Saudi J Gastroenterol       Date:  2017 Sep-Oct       Impact factor: 2.485

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.